My Longevity Journey

  Sesame oil (+ vit E) (30 ml/day = 2 tablespoons) was shown to beneficially affect several cardiometabolic indices (including lipids, FBG, BP, HOMA-IR, and MDA) in patients with MetS. Lowers Blood Pressure. Sesame oil and vitamin E co-administration may improve cardiometabolic risk factors in patients with metabolic syndrome: a randomized clinical trial Objectives: Metabolic syndrome (MetS) represents a clustering of metabolic abnormalities that are associated with an increased risk of type 2 diabetes and cardiovascular disease. We aimed to evaluate the effects of sesame oil enriched with vitamin E (vit E), sesame oil alone and sunflower oil on lipid profile, fasting blood glucose (FBG), malondialdehyde (MDA), high-sensitivity C-reactive protein (Hs-CRP), homeostatic model assessment (HOMA-IR), and blood pressure (BP) in patients with MetS. Subjects: Overall, 75 individuals with MetS (aged 30-70 years) participated in this randomized, single-blind controlled trial. Patients were rand

  Hibiscus lowers blood pressure in prehypertensive and mildly hypertensive adults, High in anthocyanins (the pigment that gives them their color and the anti-oxidant properties). Hibiscus is an alternative (sugar free) source of anthocyanins, similar to Berries.  Very tasty in combination with loose leaf green tea.  Effect of hibiscus sabdariffa on blood pressure in patients with stage 1 hypertension, 2019 Using different drug regimens has been proved to have effective effects on lowering blood pressure, but the adverse effects of long-term usage such medications is evident. According to recent trend in suing herbal and traditional medicines, researchers have been focused on evaluating the effect of different herbals on managing hypertension. The aim of the present study is the evaluation of the antihypertensive effect one of these herbs, sour tea (Hibiscus sabdariffa), on stage one hypertension. Patients with stage one hypertension who were diagnosed by a cardiologist has been includ

  In human RCTs, doses equal to or lower than 200 IU daily are associated with slightly reduced all cause mortality , Higher doses are associated with neutral or slightly increased all cause mortality.   In NAFLD/NASH patients , vit E supplementation reduced the values of liver enzymes compared to placebo ALT (−7.37 IU/L, 95% CI: −10.11 to −4.64), and AST (−5.71 IU/L, 95% CI: −9.49 to −1.); significantly improved liver function and histology. Supplementation lowered HS-CRP significantly -0.62 mg/l (95% confidence interval=−0.92, −0.31; P<0.001). Lowered IL-6 in individuals with insulin resistance.  One mice study reported + 15% increased lifespan , another reported neutral.  Delta-tocotrienol: Have promising anti-cancer evidence from cell and mice studies. Alpha-tocopherol: Evidence on cancer is mixed, close to neutral . Most and largest studies show no effect. There’s one large study which found detrimental effects on prostate cancer. One study with head-and-neck cancer found inc